Polypharmacy may increase the risk for dementia

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Polypharmacy is associated with an increased risk for dementia.

Why this matters

  • Clinicians should be careful when prescribing drugs in older patients to avoid unnecessary polypharmacy and potentially inappropriate medications.

Key results

  • Average number of drugs prescribed to patients with dementia 2 y before diagnosis was 2.54 vs 1.75 for control patients.
  • Polypharmacy was more common in patients with dementia (18.8%) compared with in control patients (10.8%).
  • Patients with dementia were more likely to be prescribed a potentially inappropriate medication than control patients (OR, 1.5-2.0).

Study design

  • Nested case-control study of 5562 patients newly diagnosed with dementia and control patients followed for 12 y.
  • Funding: National Research Foundation of Korea, Korean government.

Limitations

  • Data came from insurance claims, so the researchers did not have access to full medical records.